GPhC Suspends Superdrug Pharmacist for Discriminatory Refusal to Dispense Gender-Affirming Hormone Therapy
Date of Decision: August 6, 2026
Registrant's Role: Pharmacist
Allegations:
- The registrant, while working as the Responsible Pharmacist on 3 October 2024, was alleged to have failed to provide person-centred care by refusing to dispense Patient A’s prescribed medication: when the medication was clinically indicated; without a clinical reason and/or justification; without making enquiries of, or consulting with, Patient A’s prescriber and/or GP; without recording the decision.
- The registrant allowed a junior member of staff to convey the registrant’s concerns and dispensing decision to Patient A.
- The registrant’s conduct in refusing to dispense Patient A’s medication was discriminatory.
- In a public area of the pharmacy, the registrant communicated views contrary to NHS guidance by indicating: disagreement with the COVID-19 vaccine; that the registrant would promote people not taking the vaccine.
Outcome: 6 month suspension
GPhC Standards Breached:
- Standard 1 – Pharmacy professionals must provide person-centred care.
- Standard 2 – Pharmacy professionals must work in partnership with others.
- Standard 3 – Pharmacy professionals must communicate effectively.
- Standard 4 – Pharmacy professionals must maintain, develop and use their professional knowledge and skills.
- Standard 5 – Pharmacy professionals must use professional judgement.
- Standard 6 – Pharmacy professionals must behave in a professional manner.
Case Summary
Allegations
This case concerned a community pharmacist acting as the Responsible Pharmacist and a refusal to dispense an established repeat prescription for feminising hormone therapy to Patient A, a transgender patient.
Patient A attended their nominated pharmacy on 3 October 2024 to collect a repeat NHS prescription that had previously been supplied through the pharmacy. The prescription comprised 60 capsules of progesterone 100 mg and 16 Estradot 100 microgram patches. Patient A had been receiving the treatment for approximately 18 months. The GP had issued the prescription following specialist input, with evidence before the Committee of a shared-care arrangement involving Patient A’s GP and consultant.
Continue Reading the Full Case
Create a free account or log in to access the complete case summary.
- Full allegations considered by the GPhC
- Panel findings and reasoning
- Outcome of the investigation
- Sanctions considered and imposed on the Pharmacist
- Key professional learning points
Original Case Document
View the Full Determination Document
The original determination transcript is available to registered users.
- Download the official GPhC determination
- Full hearing transcript
- Detailed findings of fact
- Sanction reasoning
- Details of the pharmacy professionals involved
